Overview
- Neuralink publicly named two products on Friday, Telepathy for thought‑to‑computer and thought‑to‑human communication and Blindsight for delivering visual information directly to the brain.
- The company says Telepathy aims to achieve communication speeds that exceed fast human speech or typing, based on decoding signals from its N1 implant and new software tools.
- Neuralink describes Blindsight as engineering‑ready and notes the device received an FDA Breakthrough Device designation in September 2024, but the implant has not been approved for use in people.
- A recent 72‑hour hackathon video shows engineers built specific software features—voice activity detection, signal visualizations, and an early Grok voice‑agent activation—that are meant to improve usability for people with speech or motor impairments.
- Neuralink links these product goals to longer‑term ambitions to reroute motor and sensory brain signals to restore hand and walking function, but independent clinical demonstrations of restored vision or full motor recovery are still pending and will determine real‑world impact.